Skip to main content
Log in

Insulin receptor binding and degradation in IM-9 cultured human lymphocytes — Importance of extracellular degradation

  • Short Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Insulin degradation in IM-9 cultured human lymphocytes occurs extracellularly. In the presence of 0.1% bovine serum albumin, insulin degradation products are formed thatare soluble in 5% trichloroacetic acid. In the presence of 5% bovine serum albumin, the major products of insulin degradation are insoluble in 5% trichloroacetic acid and have little or no biological activity. Inhibition of binding with Concanavalin A or antireceptor antibody does not affect the rate of insulin degradation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roth J. Receptors for insulin, NSILA-s and growth hormone applications to disease states in man. Recent. Prog. Horm. Res. 31: 95, 1975.

    PubMed  CAS  Google Scholar 

  2. Steiner D.F. Insulin today. Diabetes 26: 322, 1977.

    Article  PubMed  CAS  Google Scholar 

  3. Terris S., Steiner D.F. Binding and degradation of 125I-insulin by rat hepatocytes. J. Biol. Chem. 250: 83, 1975.

    Google Scholar 

  4. Dial L.K., Myamoto S., Arquilla E.R. Modulation of 125I-insulin degradation by receptors in liver plasma membranes. Biochem. Biophys. Res. Comm. 74: 545, 1972.

    Article  Google Scholar 

  5. Freychet P., Kahn R., Roth J., Neville D.M. Insulin interactions with liver plasma membranes: independence of binding of the hormone and its degradation. J. Biol. Chem. 247: 3953, 1972.

    PubMed  CAS  Google Scholar 

  6. Flier J.S., Flier-Maratos E., Baird K., Kahn C.R. Antibodies to the insulin receptor that block insulin bind ing but fail to inhibit insulin degradation. Diabetes 26: 354 (Abst), 1975.

    Google Scholar 

  7. DeMeytes P. Insulin and growth hormone receptors. In: Blecher M. (Ed.), Methods in receptor research, vol. 9. Marcel Dekker, New York, 1976, p. 301.

    Google Scholar 

  8. Freychet P., Roth J., Neville D.M. Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem. Biophys. Res. Commun. 43: 400, 1971.

    Article  PubMed  CAS  Google Scholar 

  9. Flier J.S., Kahn C.R., Jarrett D.B., Roth J. Autoantibodies to the insulin receptor: effect on the insulin receptor interaction in IM-9 lymphocytes. J. Clin. Invest. 60: 784, 1977.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. LeCam A., Freychet P., Lenoir P. Degradation of insulin by isolated rat liver cells. Diabetes 24: 566, 1975.

    Article  CAS  Google Scholar 

  11. Hammon J.M., Jarret L. Insulin degradation by isolated fat cells and their subcellular fractions. Diabetes 24:1011, 1975.

    Article  Google Scholar 

  12. Duckworth W.C., Stentz F.B., Kitabchi A.E., Heinemann M. Site of cleavage of insulin by insulin protease. Diabetes 27: 450 (Abst.), 1978.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misbin, R.I., Mehl, T.D. Insulin receptor binding and degradation in IM-9 cultured human lymphocytes — Importance of extracellular degradation. J Endocrinol Invest 3, 77–81 (1980). https://doi.org/10.1007/BF03348223

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348223

Key-words

Navigation